Virginia Wealth Management Group Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 62.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 691 shares of the healthcare conglomerate's stock after selling 1,148 shares during the quarter. Virginia Wealth Management Group Inc.'s holdings in UnitedHealth Group were worth $362,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Donaldson Capital Management LLC raised its position in shares of UnitedHealth Group by 1.0% in the first quarter. Donaldson Capital Management LLC now owns 109,960 shares of the healthcare conglomerate's stock worth $57,591,000 after buying an additional 1,139 shares in the last quarter. Ellenbecker Investment Group raised its holdings in shares of UnitedHealth Group by 5.8% in the 1st quarter. Ellenbecker Investment Group now owns 4,280 shares of the healthcare conglomerate's stock valued at $2,242,000 after acquiring an additional 233 shares in the last quarter. CX Institutional grew its holdings in shares of UnitedHealth Group by 52.6% during the first quarter. CX Institutional now owns 16,565 shares of the healthcare conglomerate's stock worth $8,676,000 after purchasing an additional 5,712 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in UnitedHealth Group by 53.5% in the first quarter. Assenagon Asset Management S.A. now owns 1,078,472 shares of the healthcare conglomerate's stock valued at $564,850,000 after purchasing an additional 375,750 shares in the last quarter. Finally, Rockingstone Advisors LLC increased its holdings in shares of UnitedHealth Group by 103.9% in the 1st quarter. Rockingstone Advisors LLC now owns 5,334 shares of the healthcare conglomerate's stock worth $2,794,000 after buying an additional 2,718 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the company. Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. HSBC reaffirmed a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Truist Financial reissued a "buy" rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, KeyCorp decreased their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $426.52.
Get Our Latest Stock Report on UNH
UnitedHealth Group Stock Up 2.3%
Shares of NYSE:UNH traded up $7.22 during trading on Thursday, hitting $317.78. The stock had a trading volume of 9,100,631 shares, compared to its average volume of 7,113,005. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a market capitalization of $288.27 billion, a PE ratio of 20.50, a PEG ratio of 1.37 and a beta of 0.45. The firm's fifty day moving average is $395.60 and its 200 day moving average is $478.20.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.78%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.
Insider Buying and Selling
In related news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.28% of the company's stock.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report